Gao's Triple Eversion Carotid Endarterectomy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

Carotid endarterectomy (CEA), an important surgical approach for managing carotid plaque, has evolved over more than 70 years but still cannot be applied to all tandem carotid lesions (TCLs) because of the wide range of these lesions. Herein, the investigators introduce an innovative CEA, Gao's triple eversion CEA (GTE-CEA), for the treatment of TCLs.

Eligibility criteria

Qualifiers

Meet the diagnostic criteria for TCL stenosis.

Above 70% asymptomatic CCA and ICA stenosis or > 50% symptomatic CAS confirmed by DSA or CTA before surgery

Disqualifiers

Did not meet the diagnostic criteria for CAS

Asymptomatic CAS < 50% (as confirmed by DSA or CTA before surgery)

With stenosis at the opening of the CCA.

Trial design

Treatments tested in this trial

  • Gao's triple eversion carotid endarterectomy

Treatment groups

11 Participants
are divided into 1 treatment group